Home  /  Resource Library  /  CD19-Loss with Preservation of Other B Cell Lineage Features in Patients with Large B Cell Lymphoma Who Relapsed Post-Axi-Cel

CD19-Loss with Preservation of Other B Cell Lineage Features in Patients with Large B Cell Lymphoma Who Relapsed Post-Axi-Cel

ASH 2019: Three year results of a phase II study of CAR T therapy Axicabtagene ciloleucel for treatment of relapsed diffuse large b-cell lymphoma.